Cartesian Therapeutics, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $49.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $815.0K | 1.7% |
| Net Cash Flow | $48.5M | 98.3% |
Net Cash Flow Breakdown
Total Cash from Operations: $49.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $815.0K | 1.7% |
| Net Cash Flow | $48.5M | 98.3% |